Expedited IgGIgM Rapid Test for Mycoplasma Pneumoniae by Tongzhou Biotechnology

Short Description:

M.pneumoniae is one of three species of Mycoplasma that frequently cause infection in humans. M. pneumoniae most commonly causes upper respiratory tract infections, but can also cause pneumonia. The identification of the M. pneumoniae will help the administration of the disease with appropriate antibiotic treatment. This M. pneumoniae immunoassay is intended to detect M. pneumoniae antigen qualitatively. Because this one-step M. pneumoniae rapid test is easy to carry out, it is widely used as a screening test device and as an aid in the diagnostics of M. pneumoniae disease.

Product Detail

Product Tags

Tongzhou Biotechnology, a front-runner in the field of biomedical technology, takes pride in bringing forward an innovative solution lodged in accuracy and expediency – The Mycoplasma pneumoniae IgGIgM Rapid Test. Infections caused by Mycoplasma pneumoniae are a common concern in healthcare, demanding quick and accurate diagnostic methods. Our IgGIgM Rapid Test is designed to deliver just that – a rapid, yet precise, testing mechanism for detecting the presence of IgG and IgM antibodies in the serum, plasma, or whole blood samples. This highly sensitive, qualitative detection method will enable expedited diagnosis and timely treatment of Mycoplasma pneumoniae infections, which is vital in preventing complications. Our IgGIgM Rapid Test is effortlessly easy-to-use, intended for in vitro diagnostic use only. The test is conducted by simply applying the sample onto the sample well of the test device. After a mere waiting period of 10-15 minutes, the test results are visible, denoted by colored bands. Our test surpasses traditional methods not only in terms of speed but also owing to its exceptional precision.

Mycoplasma pneumoniae Rapid Test

Cat. No.

Product Description



Kit Size




Mycoplasma pneumoniae Antigen Rapid Test



20 T

See Insert



Mycoplasma Pneumoniae IgG/IgM Combo Rapid Test


25 T

Mycoplasma pneumoniae is the causative agent of respiratory tract nfectious diseases and complication of other systems. There will be a symptom with headache, fever, dry cough, and muscle pain. People of all age groups can be infected while youth, middle-aged and children under 4 years old have a higher infection rate. 30% of the infected population may have a whole lung infection.

In normal infection, MP-IgG can be detected as early as 1 week after infected, continue to rise very rapidly, peaking in about 2-4 weeks, decreasing gradually in 6 weeks, disappear in 2-3 months. Detection of MP-IgM/IgG antibody can diagnose MP infection in early stage.

Mycoplasma pneumoniae Antigen Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of Mycoplasma pneumoniae (M. pneumoniae) antigens in human throat swabs. It is intended to aid in the rapid differential diagnosis of Mycoplasma pneumoniae infections.

The Mycoplasma pneumoniae IgG/IgM Combo Rapid Test (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to Mycoplasma pneumoniae in whole blood, serum, or plasma to aid in the diagnosis of Mycoplasma pneumoniae infection.

The IgGIgM Rapid Test has been meticulously designed and engineered under stringent measures of quality control to ensure reliability and accuracy of the results. In our pursuit of contributing to better healthcare outcomes, we believe this test offers the kind of efficiency required in contemporary medical practice. Tongzhou Biotechnology, dedicated to advancing valuable biomedical innovations, presents this product as a testament to our commitment to improving global health diagnostics. The Mycoplasma pneumoniae IgGIgM Rapid Test is not just a product; it's a stepping stone towards quicker diagnoses, timely treatments, and improved patient outcomes.

  • Previous:
  • Next:
  • Leave Your Message